Christopher Hartnett ’83, a graduate of Bucknell University, was recently named senior director of process development at Assembly Biosciences, a biotechnology company developing oral therapeutics for disorders associated with the human microbiome. Hartnett has previously held positions of increasing responsibility at Neurogen, Regeneron, Savient and The Medicines Company.
Hartnett holds both bachelor’s and master’s degrees in biology from Bucknell, as well as a doctorate in biology from Yale.